In short: Farley's mention, not Dillian's — the host had been screening the baldness-drug names himself after Dillian flagged the theme in the newsletter: "there's one Absci Corporation that is — it says it's AI powered drug discovery. So I get a little skeptical there." Dillian's own position is that he knows nothing about the theme yet: "I don't know anything about it. Literally I just saw a tweet and I put it in the newsletter."
Absci is a small biotechnology company that uses AI models to design candidate drugs, including work in the hair-loss area that came up here.
Important attribution: this is Jack Farley's mention, not Dillian's. Farley had gone looking at the baldness-drug names himself after Dillian flagged the theme in his newsletter, and his reaction to the AI framing was wary — "it says it's AI powered drug discovery. So I get a little skeptical there."
Dillian's own position is a blank: "I don't know anything about it. Literally I just saw a tweet and I put it in the newsletter." He is passing on an unresearched idea deliberately, which is the whole point of the segment, not endorsing a company.
22:43I actually have been looking into some of these stocks myself. So I think probably there's one, Absci Corporation, that says it's AI powered drug discovery. So I get a little skeptical there. I think the other one is — the ticker is m—, like you have a long flowing mane such as you do, Jared, and really what it is is just extremely high-powered Rogaine, minoxidil, which — I'll be honest, I'm on minoxidil and normally the reason that they don't crank up the dosage a ton on minoxidil is because it can cause like
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.